| Clinical Trials |
|
Melbourne Health Shared Pathology Service (MHSPS) provides support and services for commercially sponsored and investigator-driven clinical trials and research projects for universities and research institutes.
Our services include specimen collection, handling, storage, multi-disciplinary analysis and reporting. MHSPS works closely with the Research Directorate to facilitate the HREC approval process.
Participating in a Clincial Trial
Do you want to participate in a clinical trial? Health Insite is an Australian Government initiative that offers a range of approved Clincial Trials that require participants. To find out more about participating in a government-approved clinical trial, follow the link to the Health Insite webpage:
Applying for Pathology Services for your Clinical Trial
 |
The Principal Investigators of all clinical trials and research projects intending to utilise the services of MHSPS should familiarise themselves with:
To apply for pathology services, Principal Investigators must complete the Application for Pathology Approval Form. |
Please allow at least two weeks for processing and approval of all new submissions. Please note, ALL clinical trials (commercial and non-commercial) and investigator driven research projects are to be submitted for approval including protocols where the testing schedule is considered standard of care. Approval and establishment fees apply.
Recent Trials
MHSPS Clinical Trials is a proven reliable and efficient provider of central laboratory services for major national and international trials, as highlighted by our pivotal coordinating role in a large number of successful, major multi-site clinical trials. Recent examples include:
- Intranasal Insulin Trial (INIT II).
-
A phase III multicenter, randomized, parallel, placebo-controlled, double-blind study to investigate the safety and efficacy of treatment with Bronchitol in the symptomatic treatment of bronchiectasis.
- Histopathology of invasive filamentous fungal infections - an international review of cases: inter-observer reproducibility and concordance with mucological culture results.
- Cognition and Lifestyle Study (AIBL Study).
- To determine whether isolation/cohorting with use of special infection control precautions for methicillin-resistant Staphylococcus aureus (MRSA) colonised patients detected using active surveillance and rapid molecular diagnostic techniques is effective in reducing acquisition of MRSA in the intensive care.
|
Health Insite 
